Microsoft’s Satya Nadella says AI models need an ‘emergency brake’
In the rapidly evolving landscape of generative artificial intelligence, the discourse has shifted from mere capability to the critical necessity of governance. Satya Nadella,...
We’re still figuring out the side effects of GLP-1 weight-loss drugs
The pharmaceutical landscape has been fundamentally altered by the meteoric rise of GLP-1 receptor agonists. Drugs like semaglutide and tirzepatide have moved from niche...
The maker of non-text AI model Jev valued at $7.5B just weeks after launch
In the fast-paced ecosystem of artificial intelligence, where multi-billion dollar valuations have become almost commonplace, a new disruptor has emerged with startling velocity. Jev,...
The Download: AI’s refusal problem and weight-loss drug side effects
In the rapidly evolving landscape of modern innovation, two distinct sectors are currently grappling with the unintended consequences of their own success. In the...
Pretend you’re sitting at Elizabeth Holmes’ desk on this weirdly detailed website
Inside the Digital Simulation: Exploring the Surreal "Elizabeth Holmes Desk" Experience
In the rapidly evolving landscape of...
The Download: AI roadblocks for humanoids and portable rubber dams
The Download: Navigating the AI Bottlenecks for Humanoids and the Rise of Portable Rubber Dams
In the...
Nous Research confirms it hit $1.5B valuation, launches AI agents for business users
Nous Research Hits $1.5 Billion Valuation: A New Era for Open-Source AI...
The Download: weight-loss drugs slowing aging and carbon dioxide batteries
In the rapidly evolving landscape of scientific innovation, the convergence of biotechnology and sustainable energy is reshaping our definition of progress. This week on...
How AI decision models could change content moderation
The digital landscape is currently witnessing a paradigm shift in how platforms manage the sheer volume of user-generated content. For over a decade, social...
Weight-loss drugs show signs of slowing biological aging, say drugmakers
Beyond the Scale: How Weight-Loss Drugs May Be Rewriting the Biological Clock
For decades, the pharmaceutical industry has treated obesity and biological aging as two...






































